Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Sees Q4 Loss of $1.2M

NEW YORK (GenomeWeb News) – Canadian molecular diagnostics firm GeneNews today said that its fourth-quarter net loss rose to C$1.2 million (US$1.2 million) from a net loss of C$1.0 million.

On a per-share basis, though, net loss for the three months ended Dec. 31, 2011 receded to C$.01, compared to C$.02 a year ago.

The Toronto-based firm did not release revenue, R&D spending, or SG&A figures and documents were not yet available on SEDAR's website.

For full-year 2011, the firm posted a net loss of C$4.5 million, or C$.05 per share, compared to a net loss of C$4.6 million, or C$.07 per share, in 2010. The improvement resulted mainly from decreases in non-cash expenses, such as share-based compensation and depreciation, it said.

GeneNews finished 2011 with C$2.1 million in cash, cash equivalents, and short-term investments.

During the year it intensified its commercialization efforts and expanded its patent portfolio and the applications of its Sentinel Principle technology to new disease areas, it said. In the fourth quarter GeneNews' marketing partner in Malyasia launched the firm's ColonSentry test in that country.

The company also expanded its management team and raised additional working capital, it said.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.